Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 1
1997 1
1998 1
2011 1
2014 2
2015 2
2016 1
2017 4
2018 9
2019 3
2020 3
2021 5
2022 3
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Sandborn WJ, Vermeire S, Peyrin-Biroulet L, Dubinsky MC, Panes J, Yarur A, Ritter T, Baert F, Schreiber S, Sloan S, Cataldi F, Shan K, Rabbat CJ, Chiorean M, Wolf DC, Sands BE, D'Haens G, Danese S, Goetsch M, Feagan BG. Sandborn WJ, et al. Among authors: cataldi f. Lancet. 2023 Apr 8;401(10383):1159-1171. doi: 10.1016/S0140-6736(23)00061-2. Epub 2023 Mar 2. Lancet. 2023. PMID: 36871574 Free article. Clinical Trial.
Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1.
Reinisch W, Hung K, Hassan-Zahraee M, Cataldi F. Reinisch W, et al. Among authors: cataldi f. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S669-S677. doi: 10.1093/ecco-jcc/jjy059. J Crohns Colitis. 2018. PMID: 29757363 Review.
Assessment of late-life depression via self-report measures: a review.
Balsamo M, Cataldi F, Carlucci L, Padulo C, Fairfield B. Balsamo M, et al. Among authors: cataldi f. Clin Interv Aging. 2018 Oct 16;13:2021-2044. doi: 10.2147/CIA.S178943. eCollection 2018. Clin Interv Aging. 2018. PMID: 30410319 Free PMC article. Review.
Challenges and Opportunities in IBD Clinical Trial Design.
Dubinsky MC, Collins R, Abreu MT; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Dubinsky MC, et al. Gastroenterology. 2021 Aug;161(2):400-404. doi: 10.1053/j.gastro.2021.03.065. Epub 2021 Apr 20. Gastroenterology. 2021. PMID: 33864796 Free article. No abstract available.
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE).
Chang L, Cash BD, Lembo A, Kunkel DC, English BA, Lindstrom B, Gu G, Skare S, Gilder K, Turner S, Cataldi F, Lipkis D, Tack J. Chang L, et al. Among authors: cataldi f. Neurogastroenterol Motil. 2023 May;35(5):e14539. doi: 10.1111/nmo.14539. Epub 2023 Feb 5. Neurogastroenterol Motil. 2023. PMID: 36740814 Clinical Trial.
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
Vermeire S, Danese S, Sandborn WJ, Schreiber S, Hanauer S, D'Haens G, Nagy P, Thakur M, Bliss C, Cataldi F, Goetsch M, Gorelick KJ, Reinisch W. Vermeire S, et al. Among authors: cataldi f. J Crohns Colitis. 2023 Dec 14:jjad199. doi: 10.1093/ecco-jcc/jjad199. Online ahead of print. J Crohns Colitis. 2023. PMID: 38096402
The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.
Verstockt B, Vermeire S, Peyrin-Biroulet L, Mosig R, Feagan BG, Colombel JF, Siegmund B, Rieder F, Schreiber S, Yarur A, Panaccione R, Dubinsky M, Lichtiger S, Cataldi F, Danese S. Verstockt B, et al. Among authors: cataldi f. J Crohns Colitis. 2023 Nov 11:jjad192. doi: 10.1093/ecco-jcc/jjad192. Online ahead of print. J Crohns Colitis. 2023. PMID: 37952114
Low back pain among Italian runners: A cross-sectional survey.
Maselli F, Esculier JF, Storari L, Mourad F, Rossettini G, Barbari V, Pennella D, Cataldi F, Viceconti A, Geri T, Testa M. Maselli F, et al. Among authors: cataldi f. Phys Ther Sport. 2021 Mar;48:136-145. doi: 10.1016/j.ptsp.2020.12.023. Epub 2021 Jan 4. Phys Ther Sport. 2021. PMID: 33434869
39 results